SYNKLINO

Owners

Goods & Services

Scientific research; scientific laboratory services; scientific research into stem cells; culturing of cells for scientific research purposes; scientific and medical research services for research and development in the field of immunology; pharmaceutical research; development of pharmaceutical preparations; pharmaceutical research and development services; development of pharmaceutical preparations and medications; carrying out clinical trials for pharmaceutical products; laboratory research on pharmaceutical preparations; consultancy in the field of drug research and development; software as a service (SAAS) services featuring software for gathering, tracking, analyzing and activating data in relation to transformative therapies for high-risk immunocompromised patients and transplant recipients

Surgical apparatus and instruments for medical use; medical diagnostic test instruments for use in immunoanalytical procedures; medical diagnostic testing apparatus for use in medical immunoassay procedures; medical devices for regenerating stem cells for medical purposes; medical apparatus for cell sampling; pharmaceutical instruments and apparatus provided empty used for the inhalation of pharmaceuticals

Pharmaceutical preparations for the prevention of chronic viral infections in high-risk immunocompromised patients and transplant recipients; pharmaceutical preparations for regulating the immune system for high-risk immunocompromised patients and transplant recipients; pharmaceutical preparations for use in organ transplantation for elimination of chronic viral infections; pharmaceutical preparations for the prevention of diseases of the immune system; immunosuppressants for use following transplantation to prevent graft rejection; pharmaceutical preparations for the treatment of immune system related diseases and disorders; immunotherapeutic agents for treatment of bacterial infections; pharmaceutical preparations for immunity adjustment for high-risk immunocompromised patients and transplant recipients; pharmaceutical preparations containing stem cells for high-risk immunocompromised patients and transplant recipients; immunoassay reagents for medical use; pharmaceutical preparations for the treatment of viral diseases; anti-viral agents; protein synthesis inhibitors for high-risk immunocompromised patients and transplant recipients; regulatory proteins being pharmaceutical preparations for medical use for high-risk immunocompromised patients and transplant recipients; pharmaceutical drugs for high-risk immunocompromised patients and transplant recipients; antibacterial pharmaceuticals